Skip to content
value.today

Velomedix Inc.

Total raised
$18 M
3 rounds on record
Latest round
$9 M
Dec 2011
First round on record
Oct 2009
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Velomedix Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2011$9 MNo. 3$2 to $10 million

Velomedix Inc.: Raise no. 3, Dec 2011

Investors in this round

17 investors had bought by the notice of Dec 27, 2011: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $11 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeff Gold · Executive Officer, Director
  • Andrew Cleeland · Director
  • Daniel Burnett · Director
  • Jim Dennis · Director
  • Ken Ludlum · Director
  • Marc Galletti · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The actual total offering amount: $10,696,885.31; The actual amount sold: $9,291,198.41”

Signed by Jeff Gold, President & CEO. Source: SEC Form D, newest notice filed Dec 27, 2011. Read the notice at the SEC.

equity, debt, optionsSEC
Oct 2010$5 MNo. 2$2 to $10 million

Velomedix Inc.: Raise no. 2, Oct 2010

Investors in this round

15 investors had bought by the notice of Nov 8, 2011: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $6 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeff Gold · Executive Officer, Director
  • Andrew Cleeland · Director
  • Daniel Burnett · Director
  • Ken Ludlum · Director
  • Marc Galletti · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount is $5,523,028.45”

Signed by Jeff Gold, President & Chief Executive Officer. Source: SEC Form D and 2 amendments, newest notice filed Nov 8, 2011. Read the notice at the SEC.

debt, optionsSEC
Oct 2009$4 MNo. 1$2 to $10 million

Velomedix Inc.: Raise no. 1, Oct 2009

Investors in this round

1 investor had bought by the notice of Nov 9, 2009: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • J. Casey McGlynn · Executive Officer
  • Jeff Gold · Executive Officer, Director
  • John Dean · Executive Officer, Director
  • Daniel Burnett · Director
  • Ken Ludlum · Director
  • Marc Galletti · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Series A-2 Preferred Stock”

Signed by John Dean, President & Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 9, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Velomedix Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2011).

    SEC Form D · Dec 2011

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Dec 2011

That is all the official record says: Velomedix Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Velomedix Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 17 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Velomedix Inc.
NameRoleNamed in
Jeff GoldExecutive officerDec 2011
Casey McGlynnExecutive officerNov 2010
John DeanExecutive officerNov 2010
J. Casey McGlynnExecutive officerNov 2009
Andrew CleelandDirectorDec 2011
Daniel BurnettDirectorDec 2011
Jeff GoldDirectorDec 2011
Jim DennisDirectorDec 2011
Ken LudlumDirectorDec 2011
Marc GallettiDirectorDec 2011
John DeanDirectorNov 2010